Bausch + Lomb acquires Elios Vision
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global eye health company, has announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS procedure, a clinically validated, minimally invasive glaucoma surgery (MIGS) procedure. According to Bausch + Lomb, the acquisition offers opportunities to treat glaucoma effectively in conjunction with cataract surgery without implants…